相关实验视频
Updated: Jun 15, 2025
08:17
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
21.0K
免疫杀手细胞治疗之前治疗的IV期NSCLC患者的免疫杀手细胞治疗
Yen-Han Tseng1,2, Ching-Liang Ho3, Chih-Feng Chian4
1Department of Chest Medicine, Taipei Veterans General Hospital, No.201, Sec. 2, Shipai Rd., Beitou District, Taipei, 112, Taiwan.
Scientific reports
|August 21, 2024
概括
免疫杀手细胞 (IKC) 在化疗失败后显示出治疗高级非小细胞肺癌 (NSCLC) 的前景. 这种免疫疗法改善了IV期NSCLC患者的无进展生存率和整体生存率.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 临床试验 临床试验
背景情况:
- 第四期非小细胞肺癌 (NSCLC) 的预后不好.
- 化疗和向疗法在晚期NSCLC中经常失败.
- 细胞免疫疗法提供了一种新的治疗方法.
研究的目的:
- 评估免疫杀手细胞 (IKC) 在IV期NSCLC患者的疗效和安全性.
- 评估那些已经耗尽了先前化疗选择的患者的IKC治疗.
- 确定IKC对无进展生存期 (PFS),总生存期 (OS),疼痛和生活质量 (QOL) 的影响.
主要方法:
- 一项临床试验涉及26名患有IV期非小细胞癌的患者.
- 患者至少有两种化疗线+/-向治疗失败.
- 免疫杀手细胞 (IKC) 每周给药,持续24周.
主要成果:
- 平均PFS为3.8个月 (ITT) 和5.6个月 (PP).
- 一年生存率为60.0% (ITT) 和85.7% (PP).
- IKC输液耐受性很好,只有3.5%的不良事件 (AEs) 与治疗相关 (级别1).
结论:
- 免疫杀手细胞 (IKC) 显示出作为第四阶段NSCLC的治疗策略的潜力.
- 与历史数据相比,IKC治疗延长了PFS和改善了生存率.
- 这种新型免疫疗法在重度预先治疗的NSCLC患者中是安全的,并且耐受性良好.
相关概念视频
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:27Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K